y 26763 has been researched along with fasudil in 1 studies
Studies (y 26763) | Trials (y 26763) | Recent Studies (post-2010) (y 26763) | Studies (fasudil) | Trials (fasudil) | Recent Studies (post-2010) (fasudil) |
---|---|---|---|---|---|
33 | 0 | 4 | 965 | 40 | 552 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, H; Fukuda, T; Hirata, KI; Miyata, M; Nakamura, K; Rikitake, Y; Tagashira, T; Takai, Y | 1 |
1 other study(ies) available for y 26763 and fasudil
Article | Year |
---|---|
Afadin Facilitates Vascular Endothelial Growth Factor-Induced Network Formation and Migration of Vascular Endothelial Cells by Inactivating Rho-Associated Kinase Through ArhGAP29.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Benzopyrans; Cell Movement; Cells, Cultured; GTPase-Activating Proteins; Human Umbilical Vein Endothelial Cells; Humans; Microfilament Proteins; Mutation; Neovascularization, Physiologic; Protein Kinase Inhibitors; Pseudopodia; rho-Associated Kinases; Shelterin Complex; Signal Transduction; Telomere-Binding Proteins; Vascular Endothelial Growth Factor A | 2018 |